Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development

Hsa-miRNA-326 (miR-326) has recently been discovered having anticancer efficacy in different organs. However, the role of miR-326 on non-small cell lung cancer (NSCLC) is still ambiguous. In this study, we investigated the role of miR-326 on the development of NSCLC. The results indicated that miR-3...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Chengcao, Huang, Chuanfeng, Li, Shujun, Yang, Cuili, Xi, Yongyong, Wang, Liang, Zhang, Feng, Fu, Yunfeng, Li, Dejia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884997/
https://www.ncbi.nlm.nih.gov/pubmed/26840018
http://dx.doi.org/10.18632/oncotarget.7071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884997/
https://www.ncbi.nlm.nih.gov/pubmed/26840018
http://dx.doi.org/10.18632/oncotarget.7071

Ejemplares similares